<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Deja, Marek A.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">New Observations from STICH</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">21-22</style></pages><abstract><style  face="normal" font="default" size="100%">Mitral valve repair during coronary artery bypass grafting (CABG) may be associated with improved survival compared with CABG alone in patients with low left ventricular ejection fraction and moderate to severe mitral regurgitation, according to new findings from the Surgical Treatment for Ischemic Heart Failure trial [STICH; NCT00023595].</style></abstract><number><style face="normal" font="default" size="100%">10</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>